Alphadyne Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3,738
Closed -$3.82M 1033
2026
Q1
$3.44M Buy
+3,738
New +$3.79M 0.06% 363
2025
Q3
Sell
-511
Closed -$380K 326
2025
Q2
$398K Buy
+511
New +$397K 0.07% 106
2023
Q4
Sell
-6,342
Closed -$3.7M 105
2023
Q3
$3.41M Buy
6,342
+5,322
+522% +$2.74M 0.26% 79
2023
Q2
$478K Buy
+1,020
New +$428K 0.06% 85

Other funds holding LLY

Alphadyne Asset Management's LLY Position: Q2 2026 in Review

Alphadyne Asset Management sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 3,738 shares — an estimated $3.82M sold.

Alphadyne Asset Management first reported a position in LLY in Q2 2023 and held it in 4 quarters. The position peaked at $3.44M in Q1 2026. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Alphadyne Asset Management reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Alphadyne Asset Management sold 3,738 Eli Lilly shares in Q2 2026, an estimated $3.82M.
  • Alphadyne Asset Management first reported a position in Eli Lilly in Q2 2023 and held it in 4 quarters.
  • Alphadyne Asset Management's Eli Lilly position peaked at $3.44M in Q1 2026.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alphadyne Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.